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1. Introduction 
Osteoporosis (OP) is a systemic skeletal disease 
where an increase in bone fragility is due to low 
bone mass and micro-architectural deterioration of 
bone tissue [1], which occur over a long period of 
time without clinical significance.  
Currently, OP diagnosis is mainly based on bone 
densitometric measurements (BMD in DXA scans) 
at various sites, but over half of the fragility 
fractures in the population arise in women that 
would not be considered at risk based on BMD 
alone [2]. Therefore, other tools like FRAX [3], 
which may or may not include BMD, where mainly 
developed to validate treatment prescriptions. Bone 
turnover markers are indices of bone remodeling, 
useful for monitoring the patient assessing the 
response to therapy and treatment adherence [4]. 
The cortical BMD accounts for 80% of our 
skeleton, but bone mechanical resistance strongly 
depends also on the internal spatial arrangement of 
bone structure, that has long been considered the 
second key factor of bone load-bearing capacity, in 
addition to bone density, Fig.1. 
 
Fig. 1. TC scan femoral neck section from: outer 
compact part and internal spongeous structure.  
In effects, most fractures occur in patients whose 
T-score is outside the osteoporosis range. DXA 
might not represent the elective exam, or be 
completely reliable [5], leading to the hypothesis 
that fracture risk depends not only on mass loss, but 
also on bone architecture, whose alterations are an 
independent factor of increased fragility. 
1.1 Bone Elastic Structure Test  
The Bone Elastic Structure Test, BESTEST®, is a 
recently introduced analysis that can be used to 
quantify the quality of bone micro-architecture and 
its pathological alterations induced by age, 
pathological conditions or lack of exposure to 
physiological mechanical stimuli. The test is based 
on an application of the Cell Method, a recent  
discrete method which is particularly effective from 
the point of  view of computation time, memory 
requirements and accuracy of the results [6,7]. A 
radiographic virtual biopsy of the patient, acquired 
in the proximal phalanges of the non-dominant 
hand, is converted  into a structural model and the 
response to compressive loads  along the orthogonal 
axes is computed, Fig.2.  
  
Fig. 2. Virtual biopsy of the patient and simulations.  
The results are then combined in an index that gives 
an indication of the quality of the bone structure, the 
BSI (Bone Structure Index) [8,9]. Similarly to 
DXA, the BESTEST results are expressed in terms 
of BSI_T-score, which compares the patient’s BSI 
with the mean BSI value for young Caucasian 
women (age 20-45) and measures this difference in 
number of standard deviations (SD). 
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Interpretation of BSI results match those 
typically used in bone density, as shown in Tab.1. 
Table 1. Clinical reading of BSI 
BSI T-score Bone Structure Quality 
≥ - 1 Normal 
< -1 and > 2.5 First level deficiency 
< 2.5 Significant worsening 
The aim of this study is the comparison of DXA 
and BESTEST results in a clinical application. 
2. Study population. 
The examined population consists of 12 
Caucasian women, age 39 - 74, Mean (SD) value 
62.4 (10.8) years, with a normal or osteopoenic 
DXA femoral neck and lumbar T-score and a recent 
osteoporotic fracture. The control population 
consists of 15 Caucasian women, age 47 - 74, Mean 
(SD) value 64.7 (8.4) years, who had not suffered 
from osteoporotic fractures  before the bone 
evaluation in 2015 described in [8], nor in the 
following three years (as confirmed by interview). 
The BSI T-score and the DXA femoral neck T-score 
were available for all the examined subjects. 
3. Results 
Results are summarized in Figures 2 to 5. As in 
in previous works [8, 9], there is no correlation 
between BSI and DEXA- T score. The DEXA T-
score (neck) of the two groups was not significantly 
different (p=0.05). The BSI T-score of the two 
groups was significantly different (p= 0.0001). 
4. Conclusions 
Despite the small number of subjects, these data 
seem to confirm that the BSI could be helpful for 
predicting fragility fractures and patient monitoring. 
 
Fig. 2. DXA vs. BSI results are independent. 
 
Fig. 3. Fractured group: min, max, mean, SD.  
 
Fig. 4. Control group: min, max, mean, SD.  
Conflicts of interest 
This work would not have been possible without 
the cooperation of the patients. 
Disclosure: FC is co-founder of M2TEST srl. 
References 
[1]  Lane JM et al. Osteoporosis. Clin Orthop Relat Res, 
2000, 372, 139-150. 
[2]  Pasco JA et al. The population burden of fractures 
originates in women with osteopenia, not 
osteoporosis. Osteoporos Int, 2006, 17(9), 1404-9. 
[3]  Kanis JA et al. Interpretation and use of FRAX in 
clinical practice. Osteoporos Int, 2011, 22, 2395-
411. 
[4]  Rossini M et al. Dose-dependent short-term effects 
of single high doses of oral vitamin D(3) on bone 
turnover markers. Calcif Tissue Int, 2012; 91: 365-9 
[5]  Schuit SCE et al. Fracture incidence and association 
with bone mineral density in elderly men and 
women. Bone, 2004; 34: 195–202. 
[6]  Tonti E: A Direct Discrete Formulation of Field 
Laws: The Cell Method. CMES 1, 11-26. 
[7]  Cosmi F. Numerical Evaluation of Trabecular Bone 
Alterations, MCB, 201, 12, 87-105. 
[8]  Cosmi F et al. Osteoporosis risk factors and bone 
microstructure evaluation: a population breakdown. 
Materials Today: Proceedings, 2018, 5, 26772–77. 
[9]  Cosmi F, Saracchini S. Bone Structure Evaluation: 
Perspectives In Oncology. Materials Today: 
Proceedings, 2019, 7, 455–462. 
88
